Created at 6:53 a.m. Jan, 31, 2026
Author: ishwarm
Related Note: 1756340216474 1
Rationale for change

Adding continuous is an important distinction here as continuous GnRH analogues have inhibitory activity BUT pulsatile GnRH analogues have agonist activity!

This is evidenced by the RANZCOG source provided on the card but as added proof I'll link the livertox article I was reading

https://www.ncbi.nlm.nih.gov/books/NBK547863/

Fairly straightforward preclinical science so not sure if you guys realy want a more in depth citation

Text Text
Extra
Extra (Synced)
Empty field
Personal Notes
Empty field
Missed Questions
Empty field
eTG Complete
Empty field
Talley & O'Connor
Empty field
Additional Resources
Additional Resources (Synced)
Empty field
Source
One by one
Empty field
#Malleus_CM::#Pharmacology::21_Miscellaneous_drugs_and_late_additions::01_Specialised_drugs::Relugolix_with_estradiol_and_norethisterone::03_Indications #Malleus_CM::#Pharmacology::11_Endocrine_drugs::05_Drugs_for_infertility::01_Gonadotropin-releasing_hormone_agonists::Nafarelin::03_Indications #Malleus_CM::#Yield::Medium #Malleus_CM::#Pharmacology::04_Anticancer_drugs::06_Hormonal_anticancer_drugs::03_Gonadotrophin-releasing_hormone_agonists::Leuprorelin::03_Indications #Malleus_CM::#Resources_by_Rotation::Obstetrics_&_Gynaecology #Malleus_CM::#Subjects::Obstetrics_&_Gynaecology::02_Gynaecology::03_Menopause::Menopause::10_Management #Malleus_CM::#Pharmacology::04_Anticancer_drugs::06_Hormonal_anticancer_drugs::03_Gonadotrophin-releasing_hormone_agonists::Goserelin::03_Indications #Malleus_CM::#Pharmacology::11_Endocrine_drugs::05_Drugs_for_infertility::01_Gonadotropin-releasing_hormone_agonists::Goserelin::03_Indications